CHB Investment Group LLC Trims Position in Axon Enterprise, Inc. (NASDAQ:AXON)

CHB Investment Group LLC cut its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 2.5% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 8,847 shares of the biotechnology company’s stock after selling 228 shares during the period. Axon Enterprise makes up about 2.9% of CHB Investment Group LLC’s portfolio, making the stock its 5th largest holding. CHB Investment Group LLC’s holdings in Axon Enterprise were worth $5,258,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Geode Capital Management LLC boosted its position in Axon Enterprise by 2.0% during the 3rd quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock worth $710,103,000 after acquiring an additional 35,320 shares during the period. Westfield Capital Management Co. LP increased its position in shares of Axon Enterprise by 12.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after acquiring an additional 127,769 shares in the last quarter. Champlain Investment Partners LLC raised its stake in Axon Enterprise by 13.9% during the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock valued at $272,695,000 after purchasing an additional 83,265 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Axon Enterprise by 1.6% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock valued at $224,281,000 after acquiring an additional 9,090 shares in the last quarter. Finally, Groupama Asset Managment purchased a new stake in shares of Axon Enterprise during the third quarter worth $200,000. Institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 21,834 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total value of $12,966,775.92. Following the sale, the insider now owns 154,394 shares of the company’s stock, valued at $91,691,508.72. The trade was a 12.39 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, President Joshua Isner sold 20,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total value of $12,123,000.00. Following the transaction, the president now directly owns 208,166 shares in the company, valued at approximately $126,179,820.90. This represents a 8.77 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 50,545 shares of company stock worth $30,721,337. 6.10% of the stock is owned by corporate insiders.

Axon Enterprise Price Performance

Shares of Axon Enterprise stock opened at $568.68 on Tuesday. Axon Enterprise, Inc. has a 12-month low of $246.99 and a 12-month high of $698.67. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The company’s fifty day simple moving average is $610.03 and its two-hundred day simple moving average is $452.93. The firm has a market cap of $43.36 billion, a PE ratio of 146.95, a price-to-earnings-growth ratio of 14.19 and a beta of 1.04.

Analyst Ratings Changes

A number of brokerages have weighed in on AXON. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. The Goldman Sachs Group raised their price objective on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. JMP Securities increased their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research report on Thursday, October 31st. Robert W. Baird upped their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Finally, TD Cowen started coverage on Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective for the company. One investment analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $504.92.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.